Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Oncoimmunology|October 1, 2021
Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapyDuo Yang, Xiaoli Wang, Xinna Zhou, et al.Journal for Immunotherapy of Cancer|September 28, 2022
Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancersKensuke Kaneko, Chaitanya R Acharya, Hiroshi Nagata, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective StudyGuoliang Qiao, Xiaoli Wang, Lei Zhou, et al.American Journal of Cancer Research|May 5, 2021
Serial assessment of circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapyXiaoli Wang, Guoliang Qiao, Ni Jiang, et al.Immunotherapy|June 14, 2019
Impact of synchronized anti-PD-1 with Ad-CEA vaccination on inhibition of colon cancer growthYuanyuan Sun, Suya Wang, Hainan Yang, et al.Cancer Immunology, Immunotherapy : CII|April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effectsTakuya Osada, Peter Berglund, Michael A Morse, et al.Oncoimmunology|July 7, 2017
Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibitionTakuya Osada, Michael A Morse, Amy Hobeika, et al.Oncotarget|October 14, 2015
The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusionQing-Kun Song, Jun Ren, Xin-Na Zhou, et al.Oncoimmunology|May 17, 2017
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapyJun Ren, William R Gwin, Xinna Zhou, et al.NPJ Vaccines|March 17, 2026
Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccinesXingru Ma, Robert D Marek, Susannah Gammell, et al.Pageof 4